product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Peptidoglycan
catalog :
7263-1006
quantity :
0.1 ml
price :
484 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
3F6B3 (10H6)
reactivity :
Lyme disease spirochete
application :
ELISA, immunohistochemistry, immunocytochemistry
more info or order :
citations: 1
Published Application/Species/Sample/Dilution | Reference |
---|---|
|
image
image 1 :

Published customer image: . Mouse anti peptidoglycan antibody, clone 3F6B3 (7263-1006) used for the detection of Bacillus cereus or Staphylococcus epidermidis derived biofilms by innunofluorescence. Image caption: . verlay and fluorescent images of B. cereus (A, B), S. epidermidis (C, D) biofilms, B. canadensis (E, F) and T. rex (G, H) vessels, exposed to antibodies raised against peptidoglycan, a bacterially produced glycosaminoglycan that is a component of both bacterial cell walls and the EPS they secrete. Binding of these antibodies is evident in both biofilm products, but no binding is seen of these antibodies to either dinosaur vessel. Scale bar for all images = 20 um. From: Citation: Schweitzer MH, Moyer AE, Zheng W (2016). Testing the Hypothesis of Biofilm as a Source for Soft Tissue and Cell-Like Structures Preserved in Dinosaur Bone. PLoS ONE 11(2): e0150238. doi:10.1371/journal.pone.0150238
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
7263-1006
Description :
Mouse anti Peptidoglycan
Specificity :
Peptidoglycan
TargetSpecies :
Bacterial
Host :
Mouse
Format :
Ascites
Isotypes :
IgG1
Applications :
P,E,C,IF
ApplicationTypes :
Immunohistology - Paraffin,ELISA,Immunohistology - Frozen,Immunofluorescence
Clone :
3F6B3 (10H6)
Quantity :
0.1 ml
Quantity Value :
0.1
Quantity Type :
ml
Entity Formats :
Ascites
UNSPSC :
41116161
Product Form :
Ascitic Fluid - raw
PriceGBP :
290
PriceEUR :
325
PriceUSD :
484 USD
PriceCHF :
354
PriceSEK :
3543
PriceNOK :
3560
PriceDKK :
2423
NotForSaleInCountries :
AU ,NZ
more info or order :
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.